Vyome Biosciences secures $14 million from top investors

2016-08-23 08:18:39

With the newly acquired funding Vyome Biosciences intends to push its drugs in pipeline for the treatment of antibiotic resistant acne and other opportunistic pathogens and antifungal agents By Team ABLEGlobal financial investors along with prominent Indian fund managers chose to bet big on Vyome Biosciences. New Delhi-located Vyome is a clinical-stage specialty bio-pharmaceutical company tha

Read more

India’s first home-made leprosy vaccine planned for large-scale trials in Bihar, Gujarat

2016-08-22 10:01:28

Leprosy vaccine developed by the National Institute of Immunology, New Delhi, ready for trials in Bihar and GujaratBy Team ABLEThe  first Made-in-India leprosy vaccine is set to go on trials in five districts of Bihar and Gujarat. The vaccine has been developed by the National Institute of Immunology, New Delhi and regulators in India and the US have approved the product.India had declared el

Read more

Andhra Pradesh initiates MedTech cluster

2016-08-22 09:57:42

The foundation stone for medical devices park laid near Visakhapatnam in Andhra PradeshBy Team ABLEGiving a major push to Make in India Initiative, last Friday, Andhra Pradesh Chief Minister, Mr N Chandrababu Naidu laid the foundation stone for the A P Medical Technology Park — considered to be India's first dedicated medical devices manufacturing park.The park has been planned on a governm

Read more

Hematology had the highest approval chances from Phase I (26.1%) and Oncology had the lowest (5.1%): BIO study of clinical drug development success rates

2016-08-22 09:54:59

Rare disease programs and programs that utilized selection biomarkers had higher success rates at each phase of development as per BIO’s 10-year study of clinical drug development success rates. By Team ABLEBIO—the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the US and other n

Read more

“I expect to see a surge in Indian companies developing Biosimilars” says ABLE Chief Kiran Mazumdar-Shaw

2016-08-19 09:43:22

ABLE editorial team is starting a new series of conversations with industry leaders and evangelists called ABLE-Talk. The conversations would be about the developments in industry and understand key trends in sectors and start-up ecosystem, policy environment, skill development, and comments on other major developments across the indust

Read more

“I expect to see a surge in Indian companies developing Biosimilars” says ABLE Chief Kiran Mazumdar-Shaw

2016-08-19 08:27:02

ABLE editorial team is starting a new series of conversations with industry leaders and evangelists called ABLE-Talk. The conversations would be about the developments in industry and understand key trends in sectors and start-

Read more

India announces New Biosimilar Policy to tap $35 billion global market by 2020

2016-08-19 08:16:50

India has announced the revised Guidelines on Similar Biologics to address the regulatory requirements for marketing authorization of biologics in India. The guidelines specify the regulatory pathway regarding manufacturing proc

Read more

DBT, European Commission to jointly fund innovative R&D ideas under HORIZON 2020

2016-08-18 11:15:18

The Department of Biotechnology (DBT) and the European Commission (EC) will jointly fund certain India–EU collaborative projects under the Horizon 2020.By Team ABLEHorizon 2020 (H2020), which is the biggest EU Research and Innovation program with nearly €80 billion of funding available over 7 years (2014 to 2020), shared that funding for five programs are still open till this October. This is

Read more

Karnataka Startup Cell calls for proposals under Grand Challenge

2016-08-18 11:12:32

The government in Karnataka launches Grand Challenges mode to identify 5 challenges every year, in order to seek innovative, technology-based solutions from startups.By Team ABLETo speed up technology solutions, the Karnataka Startup Cell in Karnataka Biotechnology and Information Technology Services (KBITS), in association with the IKP Knowledge Park, has launched the first call for proposals und

Read more

Stem Cell and Bone Marrow Transplantation Center to be set up in NIMS Hyderabad

2016-08-17 11:11:16

Hyderabad based NIMS and CCMB will collaborate to jointly conduct research on stem cells making them suitable for treatment.By Team ABLEIn a major push to stem cell research, Hyderabad-located Nizam’s Institute of Medical Sciences (NIMS) has signed an MoU with CSIR-led Centre for Cellular and Molecular Biology (CCMB) to develop an exclusive 28,000 square-feet facility called Stem Cell/Bone Marro

Read more